Qiming Venture Partners announced on Tuesday the final closing of its RMB-denominated Fund VI at 2.852 billion yuan ($440.3 million) as the China-based venture capital (VC) major ups its stake in early- and-growth-stage healthcare and TMT startups.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
